These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 719630

  • 1. Fecal profiles of anaerobic microflora of large bowel cancer patients and patients with nonhereditary large bowel polyps.
    Mastromarino AJ, Reddy BS, Wynder EL.
    Cancer Res; 1978 Dec; 38(12):4458-62. PubMed ID: 719630
    [Abstract] [Full Text] [Related]

  • 2. Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel.
    Ponz de Leon M, Roncucci L, di Donato P, Sacchetti C, Pezcoller C, Annoni C, Bertani C, Rebecchi P, Balli F, Galli D.
    Cancer Res; 1987 Jan 01; 47(1):305-10. PubMed ID: 3791216
    [Abstract] [Full Text] [Related]

  • 3. Fecal bacteriology of colonic polyp patients and control patients.
    Finegold SM, Flora DJ, Attebery HR, Sutter VL.
    Cancer Res; 1975 Nov 01; 35(11 Pt. 2):3407-17. PubMed ID: 1192408
    [Abstract] [Full Text] [Related]

  • 4. Fecal bile acid profiles of Japanese patients with adenomatous polyps of the large bowel: special reference to distribution, multiplicity, size and degree of dysplasia of the polyps.
    Tanida N, Hikasa Y, Shimoyama T, Setchell KD.
    Jpn J Cancer Res; 1985 Feb 01; 76(2):104-12. PubMed ID: 3920099
    [Abstract] [Full Text] [Related]

  • 5. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential.
    Burns CA, McCaughey R, Lauter CB.
    Am J Gastroenterol; 1985 Jan 01; 80(1):42-6. PubMed ID: 3966453
    [Abstract] [Full Text] [Related]

  • 6. Metabolic epidemiology of colon cancer: enzymic activity of fecal flora.
    Mastromarino A, Reddy BS, Wynder EL.
    Am J Clin Nutr; 1976 Dec 01; 29(12):1455-60. PubMed ID: 793371
    [Abstract] [Full Text] [Related]

  • 7. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel.
    Ponz de Leon M, Roncucci L, Di Donato P, Tassi L, Smerieri O, Amorico MG, Malagoli G, De Maria D, Antonioli A, Chahin NJ.
    Cancer Res; 1988 Jul 15; 48(14):4121-6. PubMed ID: 3383201
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the fecal microflora and its enzymatic activity in individuals genetically predisposed to colon cancer.
    Keathley JD, Needham CA.
    Cancer Res; 1982 Oct 15; 42(10):4284-8. PubMed ID: 7105023
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies.
    Kanazawa K, Konishi F, Mitsuoka T, Terada A, Itoh K, Narushima S, Kumemura M, Kimura H.
    Cancer; 1996 Apr 15; 77(8 Suppl):1701-6. PubMed ID: 8608565
    [Abstract] [Full Text] [Related]

  • 10. Some leads to the etiology of cancer of the large bowel.
    Hill MJ.
    Surg Annu; 1978 Apr 15; 10():135-49. PubMed ID: 345500
    [Abstract] [Full Text] [Related]

  • 11. Rectal bleeding in infancy: clinical, allergological, and microbiological examination.
    Arvola T, Ruuska T, Keränen J, Hyöty H, Salminen S, Isolauri E.
    Pediatrics; 2006 Apr 15; 117(4):e760-8. PubMed ID: 16585287
    [Abstract] [Full Text] [Related]

  • 12. Colicinogeny in colorectal cancer.
    Bures J, Horák V, Fixa B, Komárková O, Zaydlar K, Lonský V, Masurka V.
    Neoplasma; 1986 Apr 15; 33(2):233-7. PubMed ID: 3520352
    [Abstract] [Full Text] [Related]

  • 13. Composition of, and cholate transformation by, the predominant fecal flora of patients with colon or rectal cancer and matched controls.
    Edenharder R, Hammann R.
    Prog Clin Biol Res; 1985 Apr 15; 181():305-9. PubMed ID: 4022990
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fecal steroid 21-dehydroxylase, a potential marker for colorectal cancer.
    Bokkenheuser VD, Winter J, Mosenthal AC, Mosbach EH, McSherry CK, Ayengar NK, Andrews AW, Lebherz WB, Pienta RJ, Wallenstein S.
    Am J Gastroenterol; 1983 Aug 15; 78(8):469-75. PubMed ID: 6603789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A.
    Gastroenterology; 2007 Jul 15; 133(1):24-33. PubMed ID: 17631127
    [Abstract] [Full Text] [Related]

  • 20. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E, Kordek R, Biernat W, Tureaud J, Liberski PP, Majumdar AP.
    Hepatogastroenterology; 1997 Jul 15; 44(14):435-40. PubMed ID: 9164515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.